APC Cardiovascular Ltd.
- Home
- Companies
- APC Cardiovascular Ltd.
- Products
- EmboCept - Model S DSM 50 µm - ...
EmboCept - Model S DSM 50 µm - Interventional Therapies
EmboCept® S DSM 50 µm is certified for chemoembolization of inoperable liver and lung tumours (DSM-TACE).
Most popular related searches
interventional therapy
arterial bloodflow
lung tumor
blood flow
arterial blood
trans-arterial chemoembolisation
vascular blood
arterial flow
vascular flow
tumor specificity
- Material: Amilomer (DSM* 35/50)
- Half-Life: 30-40 Minutes
- Average Size of Microspheres: 50 µm ± 7 um
- Size Distribution of Microspheres: Min 95% 20-90 µm // Max 4.0% > 90 µm // Max 2.5% > 20 µm
- Indication: Transarterial chemoembolization (TACE) of inoperable liver and lung tumours.
- Dosage: 2.5 – 7.5 ml (150 – 450 mg), depending on tumour size and vascularization, arterial blood flow and arteriovenous shunt volume. Maximum dose of 15 ml (900 mg) possible in individual cases.
- Mechanism of Action: Reduction of blood flow causes short term ischemia in addition to a local concentration increase of the simultaneously applied cytostatic agent.
- Package Size: 450 mg Amilomer in 7.5 ml saline solution.